SODIUM PHOSPHATE

Colon Carcinoma

Region SkanemixturePhase 3Active

CCC

54/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 49/ 100
Competitive Position: 65/ 100

Competitive context

153 Active assets in the Colon Carcinoma cohort.

Asset / Sponsor	Phase	Rating
Floxuridine City of Hope Medical Center	Phase 2	BBB
FLUOROURACILUM Akeso	Phase 4	BB
Xaliplatin Sun Yat-sen University	Phase 3	BB
Pertuzumab IFOM ETS - The AIRC Institute of Molecular Oncology	Phase 3	BB
TRASTUZUMAB IFOM ETS - The AIRC Institute of Molecular Oncology	Phase 3	BB

View all 50 →

Same molecule, other indications

SODIUM PHOSPHATE is also rated in:

inflammatory bowel diseaseActive

BB

Indicative · Phase 3

64 / 100

polyp of colonActive

BB

Indicative · Phase 3

64 / 100

Parkinson diseaseDormant

CC

Indicative · Phase 1

47 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.